Micic S, Lalic N, Djordjevic D, Bojanic N, Bogavac-Stanojevic N, Busetto GM, et al
Videos on social media show tanned users promoting the products
ISSN 1573-7373
Safety Considerations and UK Regulatory Status Retatrutide is not MHRA-approved, meaning self-use outside clinical trials carries risks including product impurity, incorrect dosing, gastrointestinal adverse effects, and no pharmacovigilance oversight
These extensive viral protein interactions with host-specific cellular targets could trigger severe human metabolic reprogramming/dysregulation (HMRD), a rewiring of sugar-, amino acid-, lipid-, and nucleotide-metabolism(s), as well as altered or impaired bioenergetics, immune dysfunction, and redox imbalance in the body